If there is a decline of 10-15% (which is what I expect) then SNTA will finish the week in the $6.60 - $6.75 range.
If short interest declines by 15%, then a move into the $7.00 -$7.25 range.
Where ever it ends up, expect a SLOW trend upward ($.05 per week) until more concrete news is announced. SNTA is certain to trade over $15.00 per share given positive, verifiable (no-spin) news. However, any negative news or setbacks in breast cancer drugs would be devastating - probably a 50% loss in share price.
Current Market Cap is about $450MM. Institutions own 50% and they aren't budging until REAL news is available. Of the remaining shares, shorts now control about 1/3 of the float = REAL good news and they do face a squeeze, but bad news could push short interest up to levels where institutions begin to bail.
With very positive news Synta is easily a Billion $ + entity. How much? Hard to say, but I think 1.5 to 2.0 billion is reasonable. That puts Synta at $25.00/share - for a short time. Once positive news is announced there will be tremendous focus on earnings and/or partnerships. Any negative news then will push the stock back to the $10 - $15 level.
Synta is positioned now where they probably can't weather any really bad news.
Yes!When a bad news will be go out the shares going to 3 immediatly and go to 30 cents for the end of 2013.No hope longs!
The short interest will be a little more 18,5 or 19 mil..everybody know the synta sad story.